Ipca Laboratories disclosed a substantial drop in standalone net profit for the quarter ended December 2015. During the quarter, the profit of the company declined 44.18% to Rs 231.80 million from Rs 415.30 million in the same quarter previous year.
Revenues for the quarter declined 7.63% to Rs 6,841.10 million, compared with Rs 7,406.50 million for the prior year period.
Operating margin for the quarter stood at 13.05 percent as compared to 16.36 percent for the previous year period. Operating Income for the quarter was Rs 892.50 million, compared with Rs 1211.4 million in the previous year period.
Earnings per share for the quarter stood at Rs 1.84, registering 44.07% decline over previous year period.
| Quarterly Results - Standalone (Rs in mn) |
| As at | Dec - 15 | Dec - 14 | %Change |
| Revenues | 6,841.10 | 7,406.50 | (7.63) |
| Net Profit | 231.80 | 415.30 | (44.18) |
| Diluted EPS | 1.84 | 3.29 | (44.07) |
Shares of the company gained Rs 10.15, or 1.64%, to trade at Rs 629.45. The total volume of shares traded was 168,104 at the BSE (1.37 p.m., Monday).
